COVID-19 vaccines

EU lists rare spinal condition as side effect of J&J COVID-19 shot

Reuters

This is AI generated summarization, which may have errors. For context, always refer to the full article.

EU lists rare spinal condition as side effect of J&J COVID-19 shot

SIDE EFFECT. This file photo shows a box of Johnson & Johnson's COVID-19 vaccines is seen at the Forem vaccination centre in Pamplona, Spain, on April 22, 2021.

Vincent West/Reuters

Reports of this serious neurological illness was also at the heart of trial halts in the early stages of development for both AstraZeneca and J&J's shots, which are based on similar technology

Europe’s drug regulator on Thursday, November 11, recommended adding a rare type of spinal inflammation called transverse myelitis as a side effect of Johnson & Johnson’s single-dose COVID-19 vaccine.

Reports of this serious neurological illness was also at the heart of trial halts in the early stages of development for both AstraZeneca and J&J’s shots, which are based on similar technology.

Giving updates on the safety of all coronavirus shots, the European Medicines Agency (EMA) said it was assessing reports of a rare blood condition known as capillary leak syndrome (CLS) following inoculation with Moderna’s vaccine.

The EMA said it had recorded six cases of CLS and was assessing all data, but it was not yet clear if there was a causal association between the reports and the vaccine.

In CLS, fluids leak from the smallest blood vessels causing swelling and a drop in blood pressure. The condition has also been studied with vaccines from AstraZeneca and J&J.

The EMA said there was currently not enough evidence of a possible link between rare cases of multisystem inflammatory syndrome (MIS) and mRNA-based vaccines from Moderna and Pfizer-BioNTech vaccine.

The regulator is reviewing if approved coronavirus vaccines could cause MIS. The syndrome is a serious but rare condition in which different body parts become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs.

J&J and Moderna did not immediately respond to requests for comments. – Rappler.com

Add a comment

Sort by

There are no comments yet. Add your comment to start the conversation.

Summarize this article with AI

How does this make you feel?

Loading
Download the Rappler App!